To overcome these challenges, McNamara et al. designed a simple aptamer-siRNA chimera (A10-siRNA) for targeting the expression of survival genes in PSMA-expressing prostate cancer cells [161]. This evidence concerns the gene FOLH1 and prostate carcinoma.